De Coster I, AbdelGhany M, Sarakinou E, et al. Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trial.
Lancet Infect Dis 2026; published online Jan 23. https://doi.org/10.1016/S1473-3099(25)00730-3—In the Acknowledgments of this Article, the funding statement should have been “This work was funded by the Wellcome Trust [089102/Z/09/Z] and this publication was sponsored by GSK.” This correction has been made to the online version as of Feb 4, 2026, and will be made to the printed version.
The Lancet Infectious Diseases published a clinical update in Infectious Disease on 04 Feb 2026.
The item focuses on Correction to Lancet Infect Dis 2026; published online Jan 23.
https://doi.org/10.1016/S1473-3099(25)00730-3.
Review the original article for the full source wording and details.